Mnemosyne Pharmaceuticals' Other Investors

Mnemosyne Pharmaceuticals raised a round of funding on , . Investors include Clal Biotechnology Industries.

Mnemosyne Pharmaceuticals is a drug discovery venture aiming to develop small molecule therapeutics to treat schizophrenia and other cognitive and neuropsychiatric disorders. The company is exploring …

Articles about Mnemosyne Pharmaceuticals' Other Investors: